Amgen Names Yuji Orihara President, Amgen KK

05-Dec-2006

Amgen announced the appointment of Yuji Orihara to the position of president and representative director, Amgen KK, effective immediately. Amgen KK was formed in 1992 in Japan as a wholly owned subsidiary of Amgen Inc. Orihara will be responsible for all aspects of Amgen's commercial efforts in Japan and will be based at the Amgen KK headquarters in Tokyo.

Amgen is building Amgen KK to become a full commercial operation and a robust and growing clinical research operation. Over the next several years, Amgen's commercial operations in Japan are expected to expand significantly as the company prepares for the potential launch of its late-stage pipeline products. Japan is a priority market for Amgen and the company expects to increase its current staff of approximately 120 in Japan to more than 300 by 2009.

Orihara joins Amgen KK from Novartis Pharma K.K. where he most recently served as senior managing director in charge of the Oncology, Transplantation/Immunology/Infectious Diseases, and Ophthalmic Business Units. In addition, Orihara also led Business Development and Licensing as well as Market Access and Public Policy for Novartis Japan. Prior to Novartis, Orihara was the president of UCB Japan where he was successful in building a significant sales force and commercializing a series of products that yielded revenues in excess of $300 million.

Orihara received his undergraduate degree in Chemical and Applied Physics Engineering from Keio University in Tokyo and his master's degree in Business Administration from New York University.

Other news from the department people

Most read news

More news from our other portals

So close that even
molecules turn red...